T. Tsuchiya et al., Atrial ectopy originating from the posteroinferior atrium during radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia, PACE, 22(5), 1999, pp. 727-737
Citations number
19
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Atrial ectopy sometimes appears during RF ablation of the slow pathway in p
atients with atrioventricular nodal reentrant tachycardia (AVNRT). However,
its origin, characteristics, and significance are still unclear. To examin
e these issues, we analyzed 67 consecutive patients with AVNRT (60 with slo
w-fast AVNRT and 7 with fast-slow AVNRT), which was successfully eliminated
by RF ablation to the sites with a slow potential in 63 patients and with
the earliest activations of retrograde slow pathway conduction in 4 patient
s. During successful RF ablation, junctional ectopy with the activation seq
uence showing H-A-V at the His-bundle region appeared in 52 patients (group
A) and atrial ectopy with negative P waves in the inferior leads preceding
the QRS and the activation sequence showing A-H-V at the His-bundle region
appeared in 15 patients (group B). Atrial ectopy was associated with (10 p
atients) or without junctional ectopy 15 patients). Before RF ablation, ret
rograde slow pathway conduction induced during ventricular burst and/or ext
rastimulus pacing was more frequently demonstrated in group B than in group
A (9/15 [60%] vs 1/52 [2%], P < 0.002). Successful ablation site in group
A was distributed between the His-bundle region and coronary sinus ostium,
while that in group B was confined mostly to the site anterior to the coron
ary sinus ostium. In group B, atrial ectopy also appeared in 21% of the uns
uccessful RF ablations. In conclusion, atrial ectopy is relatively common d
uring slow pathway ablation and observed in 8% of RF applications overall a
nd 21% of RF applications that successfully eliminated inducible AVNRT. A t
rial ectopy appears to be closely related to successful slow pathway ablati
on among patients with manifest retrograde slow pathway function.